nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Salbutamol—chronic obstructive pulmonary disease	0.372	1	CrCtD
Levobunolol—ADRB2—chronic obstructive pulmonary disease	0.172	1	CbGaD
Levobunolol—Nadolol—Salbutamol—chronic obstructive pulmonary disease	0.0734	0.367	CrCrCtD
Levobunolol—Carteolol—Salbutamol—chronic obstructive pulmonary disease	0.0734	0.367	CrCrCtD
Levobunolol—Bupranolol—Salbutamol—chronic obstructive pulmonary disease	0.0531	0.266	CrCrCtD
Levobunolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0465	0.2	CbGbCtD
Levobunolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0458	0.197	CbGbCtD
Levobunolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0353	0.152	CbGbCtD
Levobunolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0353	0.152	CbGbCtD
Levobunolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0347	0.149	CbGbCtD
Levobunolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0347	0.149	CbGbCtD
Levobunolol—Iridocyclitis—Prednisolone—chronic obstructive pulmonary disease	0.00114	0.0502	CcSEcCtD
Levobunolol—Block heart—Arformoterol—chronic obstructive pulmonary disease	0.000608	0.0268	CcSEcCtD
Levobunolol—Block heart—Formoterol—chronic obstructive pulmonary disease	0.000608	0.0268	CcSEcCtD
Levobunolol—Depression—Roflumilast—chronic obstructive pulmonary disease	0.000379	0.0167	CcSEcCtD
Levobunolol—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.0157	CcSEcCtD
Levobunolol—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.000356	0.0157	CcSEcCtD
Levobunolol—Keratitis—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.0127	CcSEcCtD
Levobunolol—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.0122	CcSEcCtD
Levobunolol—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.000276	0.0122	CcSEcCtD
Levobunolol—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.0121	CcSEcCtD
Levobunolol—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000275	0.0121	CcSEcCtD
Levobunolol—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.012	CcSEcCtD
Levobunolol—Timolol—ADRB2—chronic obstructive pulmonary disease	0.000264	0.164	CrCbGaD
Levobunolol—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000263	0.0116	CcSEcCtD
Levobunolol—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.0114	CcSEcCtD
Levobunolol—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.0113	CcSEcCtD
Levobunolol—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000257	0.0113	CcSEcCtD
Levobunolol—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.0107	CcSEcCtD
Levobunolol—Carteolol—ADRB2—chronic obstructive pulmonary disease	0.000236	0.147	CrCbGaD
Levobunolol—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.0102	CcSEcCtD
Levobunolol—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.0098	CcSEcCtD
Levobunolol—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00938	CcSEcCtD
Levobunolol—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00938	CcSEcCtD
Levobunolol—Nadolol—ADRB2—chronic obstructive pulmonary disease	0.00021	0.131	CrCbGaD
Levobunolol—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000207	0.00912	CcSEcCtD
Levobunolol—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000203	0.00896	CcSEcCtD
Levobunolol—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000201	0.00886	CcSEcCtD
Levobunolol—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00886	CcSEcCtD
Levobunolol—Bupranolol—ADRB2—chronic obstructive pulmonary disease	0.0002	0.125	CrCbGaD
Levobunolol—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.0002	0.00881	CcSEcCtD
Levobunolol—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000193	0.00849	CcSEcCtD
Levobunolol—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000192	0.00845	CcSEcCtD
Levobunolol—Salbutamol—ADRB2—chronic obstructive pulmonary disease	0.000188	0.117	CrCbGaD
Levobunolol—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00827	CcSEcCtD
Levobunolol—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00827	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00826	CcSEcCtD
Levobunolol—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.000184	0.0081	CcSEcCtD
Levobunolol—Penbutolol—ADRB2—chronic obstructive pulmonary disease	0.000183	0.114	CrCbGaD
Levobunolol—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000179	0.00787	CcSEcCtD
Levobunolol—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.0078	CcSEcCtD
Levobunolol—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.00772	CcSEcCtD
Levobunolol—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000174	0.00767	CcSEcCtD
Levobunolol—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.00738	CcSEcCtD
Levobunolol—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00736	CcSEcCtD
Levobunolol—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00736	CcSEcCtD
Levobunolol—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000166	0.00731	CcSEcCtD
Levobunolol—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.00728	CcSEcCtD
Levobunolol—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00724	CcSEcCtD
Levobunolol—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00707	CcSEcCtD
Levobunolol—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00016	0.00707	CcSEcCtD
Levobunolol—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.00701	CcSEcCtD
Levobunolol—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.00701	CcSEcCtD
Levobunolol—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00687	CcSEcCtD
Levobunolol—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00682	CcSEcCtD
Levobunolol—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00682	CcSEcCtD
Levobunolol—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000152	0.00669	CcSEcCtD
Levobunolol—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00666	CcSEcCtD
Levobunolol—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.00661	CcSEcCtD
Levobunolol—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00659	CcSEcCtD
Levobunolol—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00644	CcSEcCtD
Levobunolol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000144	0.00635	CcSEcCtD
Levobunolol—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.00631	CcSEcCtD
Levobunolol—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000137	0.00603	CcSEcCtD
Levobunolol—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00587	CcSEcCtD
Levobunolol—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00587	CcSEcCtD
Levobunolol—Pindolol—ADRB2—chronic obstructive pulmonary disease	0.000132	0.0822	CrCbGaD
Levobunolol—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000131	0.00575	CcSEcCtD
Levobunolol—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00568	CcSEcCtD
Levobunolol—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.00566	CcSEcCtD
Levobunolol—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00566	CcSEcCtD
Levobunolol—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00566	CcSEcCtD
Levobunolol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00563	CcSEcCtD
Levobunolol—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00554	CcSEcCtD
Levobunolol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00551	CcSEcCtD
Levobunolol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00534	CcSEcCtD
Levobunolol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000121	0.00534	CcSEcCtD
Levobunolol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.00525	CcSEcCtD
Levobunolol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00507	CcSEcCtD
Levobunolol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00507	CcSEcCtD
Levobunolol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000114	0.00504	CcSEcCtD
Levobunolol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00504	CcSEcCtD
Levobunolol—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00499	CcSEcCtD
Levobunolol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.00495	CcSEcCtD
Levobunolol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000111	0.00488	CcSEcCtD
Levobunolol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.00484	CcSEcCtD
Levobunolol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00011	0.00484	CcSEcCtD
Levobunolol—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00479	CcSEcCtD
Levobunolol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00479	CcSEcCtD
Levobunolol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00477	CcSEcCtD
Levobunolol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000108	0.00475	CcSEcCtD
Levobunolol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000107	0.00471	CcSEcCtD
Levobunolol—Pain—Formoterol—chronic obstructive pulmonary disease	0.000105	0.00464	CcSEcCtD
Levobunolol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.00464	CcSEcCtD
Levobunolol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.0046	CcSEcCtD
Levobunolol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00457	CcSEcCtD
Levobunolol—Pain—Montelukast—chronic obstructive pulmonary disease	0.000103	0.00454	CcSEcCtD
Levobunolol—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00448	CcSEcCtD
Levobunolol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000101	0.00447	CcSEcCtD
Levobunolol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.00447	CcSEcCtD
Levobunolol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000101	0.00446	CcSEcCtD
Levobunolol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000101	0.00444	CcSEcCtD
Levobunolol—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00443	CcSEcCtD
Levobunolol—Pain—Salbutamol—chronic obstructive pulmonary disease	9.94e-05	0.00438	CcSEcCtD
Levobunolol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.78e-05	0.00431	CcSEcCtD
Levobunolol—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.78e-05	0.00431	CcSEcCtD
Levobunolol—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.61e-05	0.00423	CcSEcCtD
Levobunolol—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.58e-05	0.00422	CcSEcCtD
Levobunolol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	9.58e-05	0.00422	CcSEcCtD
Levobunolol—Headache—Tiotropium—chronic obstructive pulmonary disease	9.55e-05	0.00421	CcSEcCtD
Levobunolol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	9.55e-05	0.00421	CcSEcCtD
Levobunolol—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.00413	CcSEcCtD
Levobunolol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	9.23e-05	0.00407	CcSEcCtD
Levobunolol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	9.07e-05	0.004	CcSEcCtD
Levobunolol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	9.07e-05	0.004	CcSEcCtD
Levobunolol—Nausea—Tiotropium—chronic obstructive pulmonary disease	9.06e-05	0.00399	CcSEcCtD
Levobunolol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	9.04e-05	0.00398	CcSEcCtD
Levobunolol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.88e-05	0.00391	CcSEcCtD
Levobunolol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.83e-05	0.00389	CcSEcCtD
Levobunolol—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.83e-05	0.00389	CcSEcCtD
Levobunolol—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.71e-05	0.00384	CcSEcCtD
Levobunolol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.71e-05	0.00384	CcSEcCtD
Levobunolol—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.65e-05	0.00381	CcSEcCtD
Levobunolol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.56e-05	0.00377	CcSEcCtD
Levobunolol—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.53e-05	0.00376	CcSEcCtD
Levobunolol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	8.42e-05	0.00371	CcSEcCtD
Levobunolol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	8.42e-05	0.00371	CcSEcCtD
Levobunolol—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	8.38e-05	0.00369	CcSEcCtD
Levobunolol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	8.34e-05	0.00367	CcSEcCtD
Levobunolol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	8.25e-05	0.00363	CcSEcCtD
Levobunolol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8.22e-05	0.00362	CcSEcCtD
Levobunolol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	8.14e-05	0.00359	CcSEcCtD
Levobunolol—Dizziness—Formoterol—chronic obstructive pulmonary disease	8.14e-05	0.00359	CcSEcCtD
Levobunolol—Dizziness—Montelukast—chronic obstructive pulmonary disease	7.97e-05	0.00351	CcSEcCtD
Levobunolol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	7.95e-05	0.0035	CcSEcCtD
Levobunolol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.00346	CcSEcCtD
Levobunolol—Headache—Formoterol—chronic obstructive pulmonary disease	7.71e-05	0.0034	CcSEcCtD
Levobunolol—Headache—Arformoterol—chronic obstructive pulmonary disease	7.71e-05	0.0034	CcSEcCtD
Levobunolol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.69e-05	0.00339	CcSEcCtD
Levobunolol—Depression—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.00334	CcSEcCtD
Levobunolol—Headache—Montelukast—chronic obstructive pulmonary disease	7.55e-05	0.00333	CcSEcCtD
Levobunolol—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.32e-05	0.00323	CcSEcCtD
Levobunolol—Nausea—Formoterol—chronic obstructive pulmonary disease	7.31e-05	0.00322	CcSEcCtD
Levobunolol—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.31e-05	0.00322	CcSEcCtD
Levobunolol—Headache—Salbutamol—chronic obstructive pulmonary disease	7.28e-05	0.00321	CcSEcCtD
Levobunolol—Propranolol—ADRB2—chronic obstructive pulmonary disease	7.2e-05	0.0448	CrCbGaD
Levobunolol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	7.18e-05	0.00316	CcSEcCtD
Levobunolol—Nausea—Montelukast—chronic obstructive pulmonary disease	7.16e-05	0.00316	CcSEcCtD
Levobunolol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	6.94e-05	0.00306	CcSEcCtD
Levobunolol—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.9e-05	0.00304	CcSEcCtD
Levobunolol—Shock—Prednisolone—chronic obstructive pulmonary disease	6.56e-05	0.00289	CcSEcCtD
Levobunolol—Propranolol—CYP1A1—chronic obstructive pulmonary disease	6.18e-05	0.0384	CrCbGaD
Levobunolol—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.00268	CcSEcCtD
Levobunolol—Alopecia—Prednisone—chronic obstructive pulmonary disease	6.03e-05	0.00265	CcSEcCtD
Levobunolol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.99e-05	0.00264	CcSEcCtD
Levobunolol—Propranolol—CYP1A2—chronic obstructive pulmonary disease	5.96e-05	0.0371	CrCbGaD
Levobunolol—Pain—Prednisolone—chronic obstructive pulmonary disease	5.7e-05	0.00251	CcSEcCtD
Levobunolol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.49e-05	0.00242	CcSEcCtD
Levobunolol—Syncope—Prednisone—chronic obstructive pulmonary disease	5.32e-05	0.00235	CcSEcCtD
Levobunolol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.3e-05	0.00233	CcSEcCtD
Levobunolol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.0023	CcSEcCtD
Levobunolol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.91e-05	0.00216	CcSEcCtD
Levobunolol—Shock—Prednisone—chronic obstructive pulmonary disease	4.77e-05	0.0021	CcSEcCtD
Levobunolol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.41e-05	0.00194	CcSEcCtD
Levobunolol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.00192	CcSEcCtD
Levobunolol—Headache—Prednisolone—chronic obstructive pulmonary disease	4.18e-05	0.00184	CcSEcCtD
Levobunolol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.99e-05	0.00176	CcSEcCtD
Levobunolol—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.96e-05	0.00174	CcSEcCtD
Levobunolol—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.85e-05	0.0017	CcSEcCtD
Levobunolol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.57e-05	0.00157	CcSEcCtD
Levobunolol—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.48e-05	0.00153	CcSEcCtD
Levobunolol—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.43e-05	0.00151	CcSEcCtD
Levobunolol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.31e-05	0.00146	CcSEcCtD
Levobunolol—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.2e-05	0.00141	CcSEcCtD
Levobunolol—Headache—Prednisone—chronic obstructive pulmonary disease	3.03e-05	0.00134	CcSEcCtD
Levobunolol—Nausea—Prednisone—chronic obstructive pulmonary disease	2.88e-05	0.00127	CcSEcCtD
